BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1
1578 results:

  • 1. Cytotoxic effect of Rotheca serrata on cancer cell lines MCF-7 and neuroblastoma SH-SY5Y.
    Gadade JP; Patil SA
    J Cancer Res Ther; 2024 Jan; 20(1):181-188. PubMed ID: 38554318
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents-Comparative Studies on Normal and Immortalized cell Lines, and on
    Uram Ł; Pieńkowska N; Misiorek M; Szymaszek Ż; Twardowska M; Siorek M; Wołowiec S
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542198
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
    Saeed AM; Bentzen SM; Ahmad H; Pham L; Woodworth GF; Mishra MV
    Radiat Oncol; 2024 Mar; 19(1):36. PubMed ID: 38481255
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted Modification of Epigenetic Marks Using CRISPR/dCas9-SunTag-Based Modular Epigenetic Toolkit.
    Song MK; Kim YS
    Methods Mol Biol; 2024; 2761():81-91. PubMed ID: 38427231
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy - An evaluation of dosimetric performances.
    Böhlen TT; Germond JF; Desorgher L; Veres I; Bratel A; Landström E; Engwall E; Herrera FG; Ozsahin EM; Bourhis J; Bochud F; Moeckli R
    Radiother Oncol; 2024 May; 194():110177. PubMed ID: 38378075
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Simulating photodynamic therapy for the treatment of glioblastoma using Monte Carlo radiative transport.
    Finlayson L; McMillan L; Suveges S; Steele D; Eftimie R; Trucu D; Brown CTA; Eadie E; Hossain-Ibrahim K; Wood K
    J Biomed Opt; 2024 Feb; 29(2):025001. PubMed ID: 38322729
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients.
    Zheng X; Fang M; Fan Y; Sun Y; Sun M; Yang A; Zhang B; Liu Q; Liu H; Zhou X; Huang T; Qin J; Wang Z; Qin M; Shen Z; Yao S; Yang J; Wang Y; Gao M
    Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38261313
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
    Lin CC; Garralda E; Schöffski P; Hong DS; Siu LL; Martin M; Maur M; Hui R; Soo RA; Chiu J; Zhang T; Ma B; Kyi C; Tan DS; Cassier PA; Sarantopoulos J; Weickhardt A; Carvajal RD; Spratlin J; Esaki T; Rolland F; Akerley W; Deschler-Baier B; Rispoli L; Samant TS; Chowdhury NR; Gusenleitner D; Kwak EL; Askoxylakis V; De Braud F
    Oncoimmunology; 2024; 13(1):2290787. PubMed ID: 38170160
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Copper pyrithione and zinc pyrithione induce cytotoxicity and neurotoxicity in neuronal/astrocytic co-cultured cells via oxidative stress.
    Oh HN; Kim WK
    Sci Rep; 2023 Dec; 13(1):23060. PubMed ID: 38155222
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development of 3D melanoma cultures on a hyaluronic acid-based scaffold with synthetic self-assembling peptides: Electroporation enhancement.
    Zamuner A; Dettin M; Dall'Olmo L; Campana LG; Mognaschi ME; Conconi MT; Sieni E
    Bioelectrochemistry; 2024 Apr; 156():108624. PubMed ID: 38104458
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations.
    Janku F; Kim TM; Iyer G; Spreafico A; Elez E; de Jonge M; Yamamoto N; van der Wekken AJ; Ascierto PA; Maur M; Marmé F; Kiladjian JJ; Basu S; Baffert F; Buigues A; Chen C; Cooke V; Giorgetti E; Kim J; McCarthy F; Moschetta M; Dummer R
    Eur J Cancer; 2024 Jan; 196():113458. PubMed ID: 38039779
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
    Subbiah V; Hu MI; Mansfield AS; Taylor MH; Schuler M; Zhu VW; Hadoux J; Curigliano G; Wirth L; Gainor JF; Alonso G; Adkins D; Godbert Y; Ahn MJ; Cassier PA; Cho BC; Lin CC; Zalutskaya A; Barata T; Trask P; Scalori A; Bordogna W; Heinzmann S; Brose MS
    Thyroid; 2024 Jan; 34(1):26-40. PubMed ID: 38009200
    [No Abstract]    [Full Text] [Related]  

  • 13. Taxifolin inhibits melanoma proliferation/migration impeding USP18/Rac1/JNK/β-catenin oncogenic signaling.
    Xu L; Zhang L; Zhang S; Yang J; Zhu A; Sun J; Kalvakolanu DV; Cong X; Zhang J; Tang J; Guo B
    Phytomedicine; 2024 Jan; 123():155199. PubMed ID: 37995531
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Recovery of 400 Chemicals with Three Extraction Methods for Low Volumes of Human Plasma Quantified by Instrumental Analysis and In Vitro Bioassays.
    Braun G; Krauss M; Escher BI
    Environ Sci Technol; 2023 Dec; 57(48):19363-19373. PubMed ID: 37987701
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Survival of Patients With Head and Neck Merkel cell Cancer: Findings From the Pan-Canadian Merkel cell Cancer Collaborative.
    Nayak AL; Pickett AT; Delisle M; Dingley B; Mallick R; Hamilton T; Stuart H; Talbot M; McKinnon G; Jost E; Thiboutot E; Francescutti V; Samman S; Easson A; Schellenberg A; Merchant S; La J; Vanderbeck K; Wright F; Berger-Richardson D; Hebbard P; Hershorn O; Younan R; Patocskai E; Rodriguez-Qizilbash S; Meguerditichian A; Tchuente V; Kazandjian S; Mathieson A; Hossain F; Hetu J; Corsten M; Tohmé A; Nessim C; Johnson-Obaseki S
    JAMA Netw Open; 2023 Nov; 6(11):e2344127. PubMed ID: 37983027
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MicroRNA-Mediated Antiproliferative Effects of M1 Macrophage-Derived Extracellular Vesicles on Melanoma cells.
    Saleh NA; Rode MP; Cisilotto J; Silva AH; Prigol AN; da Luz Efe F; Winter E; Filippin-Monteiro FB; Creczynski-Pasa TB
    Immunol Invest; 2024 Jan; 53(1):70-89. PubMed ID: 37981469
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.
    Leidner R; Conlon K; McNeel DG; Wang-Gillam A; Gupta S; Wesolowski R; Chaudhari M; Hassounah N; Lee JB; Ho Lee L; O'Keeffe JA; Lewis N; Pavlakis GN; Thompson JA
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37907221
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lysates from the probiotic bacterium Streptococcus thermophilus enhances the survival of T cells and triggers programmed cell death in neuroblastoma cells.
    Altves S; Guclu E; Cinar Ayan I; Bilecen K; Vural H
    Med Oncol; 2023 Oct; 40(11):315. PubMed ID: 37787808
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Structure and Metabolically Oriented Efficacy of Fucoidan from Brown Alga
    Usoltseva RV; Zueva AO; Malyarenko OS; Anastyuk SD; Moiseenko OP; Isakov VV; Kusaykin MI; Jia A; Ermakova SP
    Mar Drugs; 2023 Sep; 21(9):. PubMed ID: 37755099
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?-Insights from an international population-based study.
    Kridin K; Abdelghaffar M; Mruwat N; Ludwig RJ; Thaçi D
    J Eur Acad Dermatol Venereol; 2024 Feb; 38(2):315-324. PubMed ID: 37730962
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 79.